Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Jhund PS"'
Autor:
Jhund PS; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom., Claggett BL; Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts., Talebi A; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom., Butt JH; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom., Gasparyan SB; Late-Stage Development, Cardiovascular, Renal, and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Wei LJ; Harvard T. H. Chan School of Public Health, Boston, Massachusetts., McCaw ZR; Insitro, South San Francisco, California., Wilderäng U; Late-Stage Development, Cardiovascular, Renal, and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Bengtsson O; Late-Stage Development, Cardiovascular, Renal, and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Desai AS; Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts., Petersson M; Late-Stage Development, Cardiovascular, Renal, and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Langkilde AM; Late-Stage Development, Cardiovascular, Renal, and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., de Boer RA; Erasmus Medical Center, Rotterdam, the Netherlands., Hernandez AF; Duke University Medical Center, Durham, North Carolina.; Associate Editor, JAMA Cardiology., Inzucchi SE; Yale School of Medicine, New Haven, Connecticut., Kosiborod MN; Saint Luke's Mid America Heart Institute, University of Missouri-Kansas City., Lam CSP; National Heart Centre Singapore and Duke-National University of Singapore, Singapore., Martinez FA; University of Cordoba, Cordoba, Argentina., Shah SJ; Northwestern University Feinberg School of Medicine, Chicago, Illinois., Vaduganathan M; Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts., Solomon SD; Cardiovascular Division, Brigham and Women's Hospital, Boston, Massachusetts., McMurray JJV; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom.
Publikováno v:
JAMA cardiology [JAMA Cardiol] 2023 Jun 01; Vol. 8 (6), pp. 554-563.
Autor:
Butt JH; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, UK (J.H.B., P.S.J., J.J.V.M.).; Department of Cardiology, Rigshospitalet Copenhagen University Hospital, Denmark (J.H.B.)., Jhund PS; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, UK (J.H.B., P.S.J., J.J.V.M.)., Belohlávek J; Second Department of Internal Medicine, Cardiovascular Medicine, General Teaching Hospital, First Faculty of Medicine, Charles University, Prague, Czech Republic (J.B.)., de Boer RA; Erasmus Medical Center, Rotterdam, the Netherlands (R.A.d.B.)., Chiang CE; General Clinical Research Center and Division of Cardiology, Taipei Veterans General Hospital and National Yang Ming Chiao Tung University, Taiwan (C.-E.C.)., Desai AS; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA (A.S.D.)., Drożdż J; Department of Cardiology, Medical University of Lodz, Poland (J.D.)., Hernandez AF; Duke University Medical Center, Durham, NC (A.F.H.)., Inzucchi SE; Yale School of Medicine, New Haven, CT (S.E.I.)., Katova T; Department of Noninvasive Cardiology, National Cardiology Hospital, Sofia, Bulgaria (T.K.)., Kitakaze M; Cardiovascular Division of Medicine, National Cerebral and Cardiovascular Center, Osaka, Japan (M.K.)., Kosiborod MN; Saint Luke's Mid America Heart Institute, Kansas City, MO (M.N.K.)., Lam CSP; National Heart Centre Singapore and Duke National University of Singapore (C.S.P.L.)., Maria Langkilde A; Late-Stage Development, Cardiovascular, Renal, and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden (A.M.L., D.L., E.B., M.P., U.W.)., Lindholm D; Late-Stage Development, Cardiovascular, Renal, and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden (A.M.L., D.L., E.B., M.P., U.W.)., Bachus E; Late-Stage Development, Cardiovascular, Renal, and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden (A.M.L., D.L., E.B., M.P., U.W.)., Martinez F; University of Cordoba, Argentina (F.M.)., Merkely B; Heart and Vascular Centre, Semmelweis University, Budapest, Hungary (B.M.)., Petersson M; Late-Stage Development, Cardiovascular, Renal, and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden (A.M.L., D.L., E.B., M.P., U.W.)., Saraiva JFK; Cardiovascular Division, Instituto de Pesquisa Clínica de Campinas, Brazil (J.F.K.S.)., Shah SJ; Northwestern University Feinberg School of Medicine, Chicago, IL (S.J.S.)., Vaduganathan M; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (M.V., B.C.C., S.D.S.)., Vardeny O; Minneapolis VA Center for Care Delivery and Outcomes Research, University of Minnesota (O.V.)., Wilderäng U; Late-Stage Development, Cardiovascular, Renal, and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden (A.M.L., D.L., E.B., M.P., U.W.)., Claggett BL; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (M.V., B.C.C., S.D.S.)., Solomon SD; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (M.V., B.C.C., S.D.S.)., McMurray JJV; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, UK (J.H.B., P.S.J., J.J.V.M.).
Publikováno v:
Circulation [Circulation] 2022 Oct 18; Vol. 146 (16), pp. 1210-1224. Date of Electronic Publication: 2022 Aug 27.
Autor:
Butt JH; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom; Department of Cardiology, Rigshospitalet Copenhagen University Hospital, Copenhagen, Denmark., Dewan P; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom., Jhund PS; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom., Anand IS; Department of Medicine, VA Medical Center, Minneapolis, Minnesota, USA; University of Minnesota Medical Center, University of Minnesota, Minneapolis, Minnesota, USA., Atar D; Department of Cardiology, Oslo University Hospital Ulleval, Oslo, Norway; Institute of Clinical Medicine, University of Oslo, Oslo, Norway., Ge J; Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, Shanghai, China., Desai AS; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA., Echeverria LE; Heart Failure Unit and Cardiac Transplant Program, Fundación Cardiovascular de Colombia, Floridablanca, Santander, Colombia., Køber L; Department of Cardiology, Rigshospitalet Copenhagen University Hospital, Copenhagen, Denmark., Lam CSP; National Heart Centre Singapore and Duke-National University of Singapore, Singapore., Maggioni AP; Associazione Nazionale Medici Cardiologi Ospedalieri, Florence, Italy., Martinez F; Universidad Nacional of Córdoba, Córdoba, Argentina., Packer M; Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas, Texas, USA., Rouleau JL; Institut de Cardiologie de Montréal, Université de Montréal, Montréal, Québec, Canada., Sim D; Department of Cardiology, National Heart Centre Singapore, Singapore., Van Veldhuisen DJ; Department of Cardiology, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands., Vrtovec B; University Medical Centre, Ljubljana, Slovenia., Zannad F; Inserm CIC 1433 and Université de Lorraine, Centre Hospitalier Régional Universitaire, Nancy, France., Zile MR; Medical University of South Carolina, Charleston, South Carolina, USA; Ralph H. Johnson Veterans Administration Medical Center, Charleston, South Carolina, USA., Gong J; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA., Lefkowitz MP; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA., Rizkala AR; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA., Solomon SD; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA., McMurray JJV; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom. Electronic address: john.mcmurray@glasgow.ac.uk.
Publikováno v:
Journal of the American College of Cardiology [J Am Coll Cardiol] 2022 Sep 20; Vol. 80 (12), pp. 1130-1143. Date of Electronic Publication: 2022 Aug 29.
Autor:
Butt JH; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom, and Department of Cardiology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark (J.H.B.)., Dewan P; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom (P.D., K.F.D., P.S.J., J.J.V.M.)., Merkely B; Heart and Vascular Centre, Semmelweis University, Budapest, Hungary (B.M.)., Belohlávek J; Second Department of Internal Medicine, Cardiovascular Medicine, General Teaching Hospital, First Faculty of Medicine, Charles University, Prague, Czech Republic (J.B.)., Drożdż J; Department of Cardiology, Medical University of Lodz, Lodz, Poland (J.D.)., Kitakaze M; Cardiovascular Division of Medicine, National Cerebral and Cardiovascular Center, Osaka, Japan (M.K.)., Inzucchi SE; Section of Endocrinology, Yale School of Medicine, New Haven, Connecticut (S.E.I.)., Kosiborod MN; Saint Luke's Mid America Heart Institute, University of Missouri, Kansas City, Missouri, and The George Institute for Global Health, University of New South Wales, Sydney, New South Wales, Australia (M.N.K.)., Martinez FA; Universidad Nacional de Córdoba, Córdoba, Argentina (F.A.M.)., Tereshchenko S; Department of Myocardial Disease and Heart Failure, National Medical Research Center of Cardiology of Russia, Moscow, Russia (S.T.)., Ponikowski P; Center for Heart Diseases, University Hospital, Wroclaw Medical University, Wroclaw, Poland (P.P.)., Bengtsson O; Late Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden (O.B., D.L., A.M.L., M.Sjöstrand)., Lindholm D; Late Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden (O.B., D.L., A.M.L., M.Sjöstrand)., Langkilde AM; Late Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden (O.B., D.L., A.M.L., M.Sjöstrand)., Schou M; Department of Cardiology, Herlev-Gentofte University Hospital, Herlev, Denmark (M.Schou)., Sjöstrand M; Late Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden (O.B., D.L., A.M.L., M.Sjöstrand)., Solomon SD; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts (S.D.S.)., Sabatine MS; Division of Cardiovascular Medicine and TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts (M.S.S.)., Chiang CE; General Clinical Research Center and Division of Cardiology, Taipei Veterans General Hospital and National Yang Ming Chiao Tung University, Taipei, Taiwan (C.C.)., Docherty KF; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom (P.D., K.F.D., P.S.J., J.J.V.M.)., Jhund PS; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom (P.D., K.F.D., P.S.J., J.J.V.M.)., Køber L; Department of Cardiology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark (L.K.)., McMurray JJV; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom (P.D., K.F.D., P.S.J., J.J.V.M.).
Publikováno v:
Annals of internal medicine [Ann Intern Med] 2022 Jun; Vol. 175 (6), pp. 820-830. Date of Electronic Publication: 2022 Apr 26.
Autor:
Dewan P; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK., Jackson A; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK., Jhund PS; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK., Shen L; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK., Ferreira JP; National Institute of Health and Medical Research (INSERM), Center for Clinical Multidisciplinary Research 1433, INSERM U1116, University of Lorraine, Regional University Hospital of Nancy, French Clinical Research Infrastructure Network (F-CRIN) Investigation Network Initiative-Cardiovascular and Renal Clinical Trialists (INI-CRCT), Nancy, France., Petrie MC; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK., Abraham WT; Division of Cardiovascular Medicine, Davis Heart and Lung Research Institute, Ohio State University, Columbus, OH, USA., Desai AS; Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA, USA., Dickstein K; University of Bergen, Stavanger University Hospital, Stavanger, Norway., Køber L; Rigshospitalet Copenhagen University Hospital, Copenhagen, Denmark., Packer M; Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas, TX, USA., Rouleau JL; Institut de Cardiologie de Montréal, Université de Montréal, Montréal, Canada., Solomon SD; Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA, USA., Swedberg K; Department of Molecular and Clinical Medicine, University of Gothenburg, Gothenburg, Sweden and National Heart., Zile MR; Medical University of South Carolina and Ralph H. Johnson Veterans Administration Medical Center, Charleston, SC, USA., McMurray JJV; BHF Cardiovascular Research Centre, University of Glasgow, Glasgow, UK.
Publikováno v:
European journal of heart failure [Eur J Heart Fail] 2020 Nov; Vol. 22 (11), pp. 2123-2133. Date of Electronic Publication: 2020 Apr 30.